US EditionGreenWay Herbal Products, LLC Awarded a U.S. Patent Covering a 1-to-1 Cannabidiol and Cannabidiolic Acid Cannabinoid Composition
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.3 Articles
3 Articles
GreenWay Herbal Products, LLC Awarded a U.S. Patent Covering a 1-to-1 Cannabidiol and Cannabidiolic Acid Cannabinoid Composition
GreenWay Herbal Products, LLC today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 12,496,307 on December 16, 2025, covering a 1-to-1 equimolar composition of cannabidiol (CBD) and cannabidiolic acid (CBDA) and methods of use for treating inflammation and autoimmune diseases in humans and other mammals.
mg Magazine – Cannabis News & Information
pressreach.comGreenWay Awarded U.S. Patent for CBD-CBDA Formulation
MURFREESBORO, Tenn. — GreenWay Herbal Products LLC received U.S. Patent No. 12,496,307 from the United States Patent and Trademark Office. Issued December 16, 2025, the patent covers a 1-to-1 equimolar composition of cannabidiol (CBD) and cannabidiolic acid (CBDA) along with methods of use for treating inflammation and autoimmune diseases in humans and other mammals. Titled Cannabinoid compositions and methods of using, the patent provides broa…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
